Yashar Te Behzadi

8114021, Feb 14, 2012

Dec 15, 2009

12/673326

Timothy Robertson - Belmont CA, US
Fataneh Omidvar - Danville CA, US
Yashar Behzadi - San Francisco CA, US
Lawrence Arne - Redwood City CA, US
Kenneth Rowberry - San Jose CA, US
James Hutchison - Palo Alto CA, US
Robert Leichner - Menlo Park CA, US
George Savage - Portola Valley CA, US
Andrew Thompson - Portola Valley CA, US
Mark Zdeblick - Portola Valley CA, US
Marc Kreidler - Sunnyvale CA, US
Hooman Hafezi - Redwood City CA, US
Robert Duck - San Francisco CA, US

Proteus Biomedical, Inc. - Redwood City CA

A61M 5/20
A61B 5/00

600300, 600301, 375133, 375130, 604 67, 604156

Receivers, which may be external or implantable, are provided. Aspects of receivers of the invention include the presence of one or more of: a high power-low power module; an intermediary module; a power supply module configured to activate and deactivate one or more power supplies to a high power processing block; a serial peripheral interface bus connecting master and slave blocks; and a multi-purpose connector. Receivers of the invention may be configured to receive a conductively transmitted signal. Also provided are systems that include the receivers, as well as methods of using the same. Additionally systems and methods are disclosed for using a receiver for coordinating with dosage delivery systems.

8469921, Jun 25, 2013

Dec 23, 2011

13/336956

Timothy Robertson - Belmont CA, US
Fataneh Omidvar - Danville CA, US
Yashar Behzadi - San Francisco CA, US
Lawrence Arne - Redwood City CA, US
Kenneth Rowberry - San Jose CA, US
James Hutchison - Palo Alto CA, US
Robert Leichner - Menlo Park CA, US
George Savage - Portola Valley CA, US
Andrew Thompson - Portola Valley CA, US
Mark Zdeblick - Portola Valley CA, US
Marc Kreidler - Sunnyvale CA, US
Hooman Hafezi - Redwood City CA, US
Robert Duck - San Francisco CA, US

Proteus Digital Health, Inc. - Redwood City CA

A61M 5/16

604 66, 600301, 455227

Receivers, which may be external or implantable, are provided. Aspects of receivers of the invention include the presence of one or more of: a high power-low power module; an intermediary module; a power supply module configured to activate and deactivate one or more power supplies to a high power processing block; a serial peripheral interface bus connecting master and slave blocks; and a multi-purpose connector. Receivers of the invention may be configured to receive a conductively transmitted signal. Also provided are systems that include the receivers, as well as methods of using the same. Additionally systems and methods are disclosed for using a receiver for coordinating with dosage delivery systems.

8480616, Jul 9, 2013

Mar 24, 2010

13/260073

Timothy Robertson - Belmont CA, US
Yashar Behzadi - San Francisco CA, US

Proteus Digital Health, Inc. - Redwood Ctiy CA

A61M 5/168
G08B 1/08

604 65, 604 66, 340 101, 34053912, 3405721, 600302

The subject matter disclosed herein provides a response to a dose of a substance and/or controls the administration of the dose. In one aspect, there is provided a system. The system may include a processor and at least one memory configured to provide a response determinator. The response determinator may receive therapeutic and wellness data. Moreover, the response determinator may determine a response based on the received therapeutic and wellness data. The response may represent a reaction to a substance integrated with an ingestible event marker. The determined response may be provided to, for example, a therapy controller. Related systems, methods, and articles of manufacture are also described.

8540664, Sep 24, 2013

Mar 24, 2010

13/260073

Timothy Robertson - Belmont CA, US
Yashar Behzadi - San Francisco CA, US

Proteus Digital Health, Inc. - Redwood Ctiy CA

A61M 5/168
G08B 1/08

604 65, 604 66, 340 101, 34053912, 3405721, 600302

The subject matter disclosed herein provides a response to a dose of a substance and/or controls the administration of the dose. In one aspect, there is provided a system. The system may include a processor and at least one memory configured to provide a response determinator. The response determinator may receive therapeutic and wellness data. Moreover, the response determinator may determine a response based on the received therapeutic and wellness data. The response may represent a reaction to a substance integrated with an ingestible event marker. The determined response may be provided to, for example, a therapy controller. Related systems, methods, and articles of manufacture are also described.

8545436, Oct 1, 2013

Dec 23, 2011

13/336956

Timothy Robertson - Belmont CA, US
Fataneh Omidvar - Danville CA, US
Yashar Behzadi - San Francisco CA, US
Lawrence Arne - Redwood City CA, US
Kenneth Rowberry - San Jose CA, US
James Hutchison - Palo Alto CA, US
Robert Leichner - Menlo Park CA, US
George Savage - Portola Valley CA, US
Andrew Thompson - Portola Valley CA, US
Mark Zdeblick - Portola Valley CA, US
Marc Kreidler - Sunnyvale CA, US
Hooman Hafezi - Redwood City CA, US
Robert Duck - San Francisco CA, US

Proteus Digital Health, Inc. - Redwood City CA

A61M 5/168

604 66, 600301, 455227, 3405731, 34053912, 370311, 713320

Receivers, which may be external or implantable, are provided. Aspects of receivers of the invention include the presence of one or more of: a high power-low power module; an intermediary module; a power supply module configured to activate and deactivate one or more power supplies to a high power processing block; a serial peripheral interface bus connecting master and slave blocks; and a multi-purpose connector. Receivers of the invention may be configured to receive a conductively transmitted signal. Also provided are systems that include the receivers, as well as methods of using the same. Additionally systems and methods are disclosed for using a receiver for coordinating with dosage delivery systems.

20090112178, Apr 30, 2009

Oct 24, 2008

12/258298

YASHAR BEHZADI - San Francisco CA, US

A61M 5/31

604503, 604 66

Methods are provided for associating a specific one of two or more distinct fluid transfer ports of a patient with a given fluid transfer event of fluid from a parenteral fluid delivery device. Aspects of the methods include establishing a fluid transfer connection between the parenteral fluid delivery device and the patient via one of the two or more distinct fluid transfer ports and transmitting a fluid transfer signal between the parenteral fluid delivery device and a patient associated identifier using the patient's body as a signal conduction medium. Association may result in identification of the fluid transfer port that will be, is being or has been employed for the given fluid transfer event. Also provided are systems for practicing methods of the invention.

20090326397, Dec 31, 2009

Jun 26, 2009

12/492672

Yashar Behzadi - San Francisco CA, US
Timothy Robertson - Belmont CA, US
Gregory Moon - Orinda CA, US
Olivier Colliou - Los Gatos CA, US

A61B 5/04

600508

Clinical applications for electrical tomography derived metrics are disclosed. One aspect of the present invention pertains to a method for generating clinical data by processing one or more metrics obtained via an electrical tomography. The method comprises receiving one or more metrics of an electrode stably associated with a tissue site of a subject, where the metrics are based on an induced signal of the electrode generated in response to one or more continuous electrical fields applied to the subject during an electrical tomography process. In addition, the method comprises generating clinical data of the internal organ of the subject based on the metrics.

20100185055, Jul 22, 2010

Feb 1, 2008

12/524837

Timothy Robertson - Belmont CA, US
George Savage - Portola Valley CA, US
Mark Zdeblick - Portola Valley CA, US
Yashar Behzadi - San Francisco CA, US
Benedict Costello - Berkeley CA, US
Jeremy Frank - San Francisco CA, US
Hooman Hafezi - Redwood City CA, US
Tariq Haniff - Redwood City CA, US
David O'Reilly - Palo Alto CA, US

A61B 1/00

600117

Ingestible event marker systems that include an ingestible event marker (i.e., an IEM) and a personal signal receiver are provided. Embodiments of the IEM include an identifier, which may or may not be present in a physiologically acceptable carrier. The identifier is characterized by being activated upon contact with a target internal physiological site of a body, such as digestive tract internal target site. The personal signal receiver is configured to be associated with a physiological location, e.g., inside of or on the body, and to receive a signal the IEM. During use, the IEM broadcasts a signal which is received by the personal signal receiver.